These positive and negative correlation results with the risk factors suggest that ANRIL and circANRIL expressions regulate the risk factors leading to CAD development and ANRIL and circANRIL may serve as indicator genes in CAD patients. The gene discussed is CDKN2B-AS1; the disease is coronary artery disorder.